作者: Debananda Pati , Hamid R. Habibi , Lashitew Gedamu
DOI: 10.1111/J.1432-1033.1996.0036R.X
关键词:
摘要: Recently we have demonstrated that the human hepatocellular carcinoma-derived cell lines, HepG2 and HuH7, contain gonadotropin-releasing hormone (gonadoliberin) receptors respond to various molecular forms of gonadoliberin in terms suppressed proliferation vitro. This study provides first demonstration inhibits zinc-induced production metallothionein mRNA HuH7 cells. Administration agonist (gonadoliberin-A) inhibited Zn-induced level a time-related dose-related manner. The effect gonadoliberin-A was found be specific, because concomitant treatment with antagonist (gonadoliberin-ANT) blocked inhibition accumulation. Furthermore, gonadoliberin-A-induced Zn-mediated accumulation correlate closely suppresion [3H] thymidine uptake these It is known metal-binding protein plays an important role tumor pathobiology resistance chemotherapeutic drugs. present findings may implications development effective chemotherapy for liver cancer, part, by improving sensitivity cells through suppression peptides.